By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Flexion Therapeutics 

300 TradeCenter
Suite 2460
Woburn  Massachusetts  01801  U.S.A.
Phone: 781-897-9977 Fax: 781-897-9970



Company News
Sanofi (SNY)'s Rumored Buyout Target Flexion (FLXN) Shows Off Mid-Stage Osteoarthritis Data 6/12/2017 5:47:55 AM
Flexion (FLXN) To Present New Cost-Effectiveness Data On Zilretta (FX006) At The International Society For Pharmacoeconomics And Outcomes Research 22nd International Meeting 5/22/2017 8:20:18 AM
Flexion (FLXN) Reports First Quarter 2017 Financial Results And Recent Business Highlights 5/5/2017 11:23:38 AM
Flexion (FLXN) Highlights Two Clinical Data Presentations At The Osteoarthritis Research Society International 2017 World Congress 4/28/2017 8:57:35 AM
Flexion (FLXN) Announces Pricing Of $175 Million 3.375% Convertible Senior Notes Due 2024 4/27/2017 10:51:00 AM
Flexion (FLXN) Announces Proposed Convertible Senior Notes Offering 4/26/2017 11:00:51 AM
Flexion (FLXN) To Report First-Quarter 2017 Financial Results On May 4, 2017 4/25/2017 8:48:07 AM
Sanofi Genzyme (SNY) Exec Exits to Become CMO of Flexion (FLXN)—Sanofi (SNY)'s Rumored Buyout Target 4/7/2017 5:58:25 AM
Flexion (FLXN) Announces New Drug Application For Zilretta (FX006) Accepted By U.S. FDA 2/7/2017 12:20:34 PM
Flexion (FLXN) Submits New Drug Application For Zilretta To Treat Knee Osteoarthritis Pain 12/13/2016 3:45:57 PM